NCT07816367

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-09Est. Completion: 2027-09

Enrollment target: 1,500 participants

Locations

Sun City Clinical Research, Glendale, Arizona, United States
Velocity Clinical Research, Phoenix, Phoenix, Arizona, United States
IMA Clinical Research - Phoenix, Phoenix, Arizona, United States
Preferred Research Partners, Inc., Little Rock, Arkansas, United States
Alliance Research Institute, Canoga Park, Canoga Park, California, United States
Velocity Clinical Research, Chula Vista, Chula Vista, California, United States
Ark Clinical Research, Fountain Valley, Fountain Valley, California, United States
Neurology Center of North Orange County, Fullerton, California, United States
Axiom Research, Los Angeles LLC, Glendale, California, United States
Long Beach Clinical Trials Services, Inc, Long Beach, California, United States
Accellacare - Long Beach, Long Beach, California, United States
Alliance Research Institute, Lynwood, Lynwood, California, United States
Northridge Clinical Trials, Northridge, California, United States
Pasadena Clinical Trials, Pasadena, California, United States
Paradigm Clinical Research Centers, LLC, Redding, California, United States

MigraineReflexologyPainAnxietyKinesiophobiaPostural Control

This prospective randomized controlled study aims to investigate the effects of foot massage on pain, anxiety, kinesioph…

Karabük, Turkey (Türkiye)Completed Aug 31, 2026

Migraine

A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied …

Edegem, BelgiumCompleted Jul 7, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.